Trial Profile
Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment Versus Glimepiride Both in Combination With Metformin.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Liraglutide (Primary) ; Metformin (Primary)
- Indications Heart failure; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Aug 2016 Status changed from recruiting to completed.
- 20 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.
- 01 Dec 2015 Planned number of patients changed from 80 to 60, according to ClinicalTrials.gov record.